List view / Grid view
29 May 2015 | By Victoria White
A team of researchers has found that the presence of IGFBP-1 interacted with MMP9 to promote breast cancer tumour formation in mouse models...
28 May 2015 | By Victoria White
Scientists have identified an enzyme, LOX, that possibly holds the key to preventing secondary cancers in breast cancer patients...
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
12 May 2015 | By Victoria White
Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
7 May 2015 | By Victoria White
Cardiff University scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumour forming cells...
5 May 2015 | By Victoria White
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles...
28 April 2015 | By Victoria White
A team at CSHL has published results of experiments that lay bare a previously unknown pathway activated in HER2-positive breast cancer...
23 April 2015 | By Victoria White
An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...
22 April 2015 | By Victoria White
New preclinical data demonstrates that mAbXcite therapies causes an immune cascade that successfully recruits T-cells to mount an attack against cancer...
13 April 2015 | By Victoria White
Medivir and CRT have announced a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
26 March 2015 | By Victoria White
Taconic and Cellaria have entered into a scientific collaboration to facilitate use of patient-derived xenografts in animal models for oncology research...
19 March 2015 | By Victoria White
While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted therapies is on the rise...
19 March 2015 | By Victoria White
PARP inhibitors that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault...
4 March 2015 | By The Institute of Cancer Research
Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...
